Medicare Enrolled
Dr. Stephanie Rubino, MD
Urology Physician · Latrobe, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rubino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubino?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rubino
Dr. Stephanie Rubino is an urology physician in Latrobe, PA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Rubino performed 5,292 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rubino received a total of $4,362 from 42 pharmaceutical and/or device companies across 215 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rubino is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 9% volume in PA
$4,362 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,292
Medicare services
Top 9% in PA for urology physician
Not available
Unique patients (not deduplicated)
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
2,200 | $5 | $8 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
702 | $34 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
363 | $86 | $155 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
346 | $3 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
278 | $60 | $110 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
270 | $34 | $75 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
162 | $69 | $175 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
161 | $62 | $115 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
126 | $106 | $225 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
89 | $4 | $12 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
84 | $7 | $150 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
67 | $178 | $385 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
56 | $136 | $280 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
54 | $34 | $75 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
54 | $34 | $75 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
54 | $34 | $75 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
54 | $34 | $75 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
54 | $34 | $75 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
25 | $40 | $112 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
19 | $445 | $2,000 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
17 | $282 | $500 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
15 | $105 | $400 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
14 | $116 | $780 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $160 | $400 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $68 | $176 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.6% high complexity
43.7% medium
55.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,362
Total received (2018-2024)
Avg $623/year across 7 years
Top 31% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
215
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,079
2023
$695
2022
$718
2021
$381
2020
$590
2019
$450
2018
$450
Payments by company (2024)
Astellas Pharma US Inc
$460
Sumitomo Pharma America, Inc.
$177
Boston Scientific Corporation
$102
Axonics, Inc.
$65
PFIZER INC.
$64
ABBVIE INC.
$46
Merck Sharp & Dohme LLC
$37
UROGEN PHARMA, INC.
$36
Ferring Pharmaceuticals Inc.
$32
Verity Pharmaceuticals Inc.
$23
Cumberland Pharmaceuticals, Inc.
$20
Antares Pharma, Inc.
$19
Top 3 companies account for 68.5% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,081
PFIZER INC.
$383
Sumitomo Pharma America, Inc.
$361
Allergan, Inc.
$247
Janssen Biotech, Inc.
$237
Boston Scientific Corporation
$234
Axonics, Inc.
$211
Cumberland Pharmaceuticals, Inc.
$191
UROVANT SCIENCES INC
$169
AbbVie Inc.
$119
Antares Pharma, Inc.
$104
DENTSPLY IH Inc.
$74
Allergan Inc.
$71
Ferring Pharmaceuticals Inc.
$62
TOLMAR Pharmaceuticals, Inc.
$61
Myriad Genetic Laboratories, Inc.
$60
Merck Sharp & Dohme LLC
$57
Tolmar, Inc.
$54
ABBVIE INC.
$46
Laborie Medical Technologies Corp.
$42
Verity Pharmaceuticals Inc.
$40
UROGEN PHARMA, INC.
$36
Endo Pharmaceuticals Inc.
$35
Olympus America Inc.
$33
UroGen Pharma, Inc.
$32
Mission Pharmacal Company
$28
Bayer Healthcare Pharmaceuticals Inc.
$28
Medtronic USA, Inc.
$26
Progenics Pharmaceuticals, Inc.
$23
Coloplast Corp
$22
Avadel Specialty Pharmaceuticals, LLC
$22
Merck Sharp & Dohme Corporation
$21
Dendreon Pharmaceuticals LLC
$20
Clarus Therapeutics Inc.
$19
Celgene Corporation
$16
Myovant Sciences Inc.
$16
Caldera Medical, Inc
$15
Kowa Pharmaceuticals America, Inc.
$14
Metuchen Pharmaceuticals
$14
AstraZeneca Pharmaceuticals LP
$13
C. R. BARD, INC. & SUBSIDIARIES
$12
Bayer HealthCare Pharmaceuticals Inc.
$12
Top 3 companies account for 41.8% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ALTIS · Aquoral · Axonics · Axonics r-SNM System · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · Bulkamid · CALDOLOR · Caldolor · Desara · ELIGARD · ERLEADA · Erleada · GEMTESA · JATENZO · JELMYTO · KEYTRUDA · LYNPARZA · LYNX · LoFric · MYRBETRIQ · Moses 550 DFL · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · OPDIVO · ORGOVYX · Olympus Guidewires · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · SEGLENTIS · SpaceOAR VUE System - 10mL · Stendra · TOVIAZ · Trelstar · VERIFY · XIAFLEX · XTANDI · XYOSTED · Xtandi
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
18
County median income
$72,468
Nearest hospital to ZIP centroid (approximate)
EXCELA HEALTH LATROBE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rubino is a mixed practice specialist, with above-average Medicare volume (top 9% in PA), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rubino experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Rubino performed 2,200 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rubino receive payments from pharmaceutical companies?
Yes. Dr. Rubino received a total of $4,362 from 42 companies across 215 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubino's costs compare to other urology physicians in Latrobe?
Dr. Rubino's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Latrobe
Browse urology physicians in Latrobe ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology